Technical Analysis for AGLE - Aeglea BioTherapeutics, Inc.

Grade Last Price % Change Price Change
grade A 7.9 1.41% 0.11
AGLE closed up 1.41 percent on Friday, August 16, 2019, on 24 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Flat
See historical AGLE trend table...

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish 1.41%
Shooting Star Candlestick Bearish 1.41%
Wide Bands Range Expansion 1.41%
Fell Below 20 DMA Bearish 0.00%
Wide Bands Range Expansion 0.00%
Crossed Above 20 DMA Bullish -1.00%
Wide Bands Range Expansion -1.00%

Older signals for AGLE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aeglea Biotherapeutics, Inc., a biopharmaceutical company, engages in developing engineered human enzymes for the treatment of inborn errors of metabolism and cancer. It develops AERase/AEB1102, an amino acid for the degradation of arginine in the circulation, as well as for the treatment of hyperargininemia and cancer; and AECase/AEB3103, an engineered and PEGylated human cysteine/cystine degrading enzyme that increases oxidative stress through glutathione depletion for treatment of hematologic and solid malignancies. The company also engages in developing AEMase/AEB2109, an engineered human enzyme that degrades methionine for the treatment of solid tumors; and AEB4104, an engineered human enzyme that degrades homocysteine in the circulation for the treatment of inborn error of metabolism homocystinuria. It has a strategic partnership with KBI Biopharma. Aeglea Biotherapeutics, Inc. was formerly known as Aeglea BioTherapeutics Holdings, LLC. The company was founded in 2013 and is based in Austin, Texas.
Chemistry Biopharmaceutical Cancer Solid Tumors Organic Chemistry Inborn Errors Of Metabolism
Is AGLE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.16
52 Week Low 5.99
Average Volume 172,344
200-Day Moving Average 7.6974
50-Day Moving Average 7.1464
20-Day Moving Average 8.064
10-Day Moving Average 7.898
Average True Range 0.3923
ADX 18.8
+DI 24.129
-DI 20.0423
Chandelier Exit (Long, 3 ATRs ) 7.9231
Chandelier Exit (Short, 3 ATRs ) 7.8769
Upper Bollinger Band 9.2861
Lower Bollinger Band 6.8419
Percent B (%b) 0.43
BandWidth 30.31002
MACD Line 0.1914
MACD Signal Line 0.2949
MACD Histogram -0.1035
Fundamentals Value
Market Cap 129.97 Million
Num Shares 16.5 Million
EPS -1.81
Price-to-Earnings (P/E) Ratio -4.36
Price-to-Sales 15.71
Price-to-Book 1.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.23
Resistance 3 (R3) 8.21 8.08 8.18
Resistance 2 (R2) 8.08 8.00 8.09 8.16
Resistance 1 (R1) 7.99 7.94 8.04 8.01 8.14
Pivot Point 7.86 7.86 7.88 7.87 7.86
Support 1 (S1) 7.77 7.77 7.81 7.79 7.66
Support 2 (S2) 7.64 7.72 7.65 7.64
Support 3 (S3) 7.55 7.64 7.62
Support 4 (S4) 7.57